NCT00914238

Brief Summary

In a randomized clinical trial, the researchers want to investigate if the positive short-term outcomes (first 1-2 years), achieved with specialized assertive intervention programme (OPUS), can be maintained for five years if the specialized treatment is sustained over the first five years in comparison to only two years of specialized treatment followed by three years of standard treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2009

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 4, 2009

Completed
27 days until next milestone

Study Start

First participant enrolled

July 1, 2009

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
Last Updated

October 25, 2016

Status Verified

October 1, 2016

Enrollment Period

5.9 years

First QC Date

May 28, 2009

Last Update Submit

October 24, 2016

Conditions

Keywords

Randomized clinical trialfirst episode psychosis of schizophrenia and schizotypal disorderrehabilitationpsychosocialhealth service researchschizotypal Disorder

Outcome Measures

Primary Outcomes (1)

  • Negative symptoms, measured with Schedule for Assessment of Negative Symptoms in Schizophrenia, (SANS)

    3 years

Secondary Outcomes (10)

  • Psychotic symptoms

    3 years

  • Simultaneous remission of both psychotic and negative symptoms.

    3 years

  • Substance abuse.

    3 years

  • Suicidal behaviour.

    3 years

  • Use of bed days.

    3 years

  • +5 more secondary outcomes

Study Arms (2)

5 year

EXPERIMENTAL

5 years OPUS treatment

Behavioral: OPUS 5 years

2 years of OPUS treatment

ACTIVE COMPARATOR

2 years OPUS treatment and 3 years of treatment as usual

Behavioral: 2 years OPUS treatment

Interventions

2 years OPUS and transfer to standard treatment.

2 years of OPUS treatment
OPUS 5 yearsBEHAVIORAL
5 year

Eligibility Criteria

Age18 Years - 37 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • patients aged 18 - 37 years
  • first episode psychosis in schizophrenia spectrum
  • treated for 1½ year in the five OPUS teams in the Capital Region and the OPUS teams in Region Midt
  • patients who will give signed informed consent to participate in the trial

You may not qualify if:

  • patients who are not treated in one of the OPUS team in the Capital Region and Region Midt
  • patients who don't give signed informed consent to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Psychiatric Center Bispebjerg

Copenhagen, 2400, Denmark

Location

Psychiatric Centre Bispebjerg

Copenhagen, 2400, Denmark

Location

Related Publications (5)

  • Puntis S, Minichino A, De Crescenzo F, Cipriani A, Lennox B, Harrison R. Specialised early intervention teams (extended time) for recent-onset psychosis. Cochrane Database Syst Rev. 2020 Nov 2;11(11):CD013287. doi: 10.1002/14651858.CD013287.pub2.

  • Albert N, Randers L, Allott K, Jensen HD, Melau M, Hjorthoj C, Nordentoft M. Cognitive functioning following discontinuation of antipsychotic medication. A naturalistic sub-group analysis from the OPUS II trial. Psychol Med. 2019 May;49(7):1138-1147. doi: 10.1017/S0033291718001836. Epub 2018 Jul 30.

  • Albert N, Melau M, Jensen H, Emborg C, Jepsen JR, Fagerlund B, Gluud C, Mors O, Hjorthoj C, Nordentoft M. Five years of specialised early intervention versus two years of specialised early intervention followed by three years of standard treatment for patients with a first episode psychosis: randomised, superiority, parallel group trial in Denmark (OPUS II). BMJ. 2017 Jan 12;356:i6681. doi: 10.1136/bmj.i6681.

  • Melau M, Harder S, Jeppesen P, Hjorthoj C, Jepsen JR, Thorup A, Nordentoft M. The association between working alliance and clinical and functional outcome in a cohort of 400 patients with first-episode psychosis: a cross-sectional study. J Clin Psychiatry. 2015 Jan;76(1):e83-90. doi: 10.4088/JCP.13m08814.

  • Melau M, Jeppesen P, Thorup A, Bertelsen M, Petersen L, Gluud C, Krarup G, Nordentoft M. The effect of five years versus two years of specialised assertive intervention for first episode psychosis - OPUS II: study protocol for a randomized controlled trial. Trials. 2011 Mar 10;12:72. doi: 10.1186/1745-6215-12-72.

MeSH Terms

Conditions

Schizotypal Personality DisorderPsychotic DisordersSchizophrenia

Condition Hierarchy (Ancestors)

Personality DisordersMental DisordersSchizophrenia Spectrum and Other Psychotic Disorders

Study Officials

  • Merete Nordentoft, Professor

    University of Copenhagen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 28, 2009

First Posted

June 4, 2009

Study Start

July 1, 2009

Primary Completion

June 1, 2015

Study Completion

October 1, 2016

Last Updated

October 25, 2016

Record last verified: 2016-10

Locations